Sublingual Semaglutide (generic Ozempic®) now available! Get Started
Dashboard
Compound Catalog

Ergocristine Mesylate

Ergocristine Mesylate is a potent ergot alkaloid derivative commonly utilized in compounded pharmaceutical formulations for its vasoconstrictive and uterotonic properties. This active pharmaceutical ingredient is primarily employed in the management of conditions related to vascular and uterine health, offering therapeutic benefits through its ability to modulate smooth muscle contraction.

Its mechanism of action involves the stimulation of adrenergic and serotonergic receptors, which contributes to its efficacy in clinical settings. Ergocristine Mesylate is often considered in personalized medicine approaches, where tailored dosages and combinations are essential for optimal patient outcomes. Its inclusion in compounded formulations underscores its versatility and importance in specialized therapeutic regimens.

Trusted by 60,357 patients to date.
A group of faces of our past satisfied patients.
A svg symbol of a mortar and pestle with ingredients going in.
Custom made in our compounding labs.
Sliders that show the customization of ingredients.
Personalized treatment for better results.
User with a gear showing the personalization of the formulation.
All strengths and ingredients are tailored to your needs.
This medication is not available at retail pharmacies. It is compounded, and may be more effective at treating you or your patient.
This is some text inside of a div block.
Loading icon rotating.
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.

Active Ingredient Information

A small arrow pointing down

Ergocristine Mesylate is a potent ergot alkaloid that plays a crucial role in various compounded formulations, particularly in the management of certain medical conditions. As a derivative of ergot, it exhibits vasoconstrictive properties, making it valuable in the treatment of vascular headaches and other related disorders. Its mechanism of action involves the modulation of serotonin receptors, which helps in alleviating symptoms associated with migraines and other vascular conditions.

In addition to its vasoconstrictive effects, Ergocristine Mesylate is known for its ability to influence neurotransmitter pathways, providing therapeutic benefits in neurological applications. This API is often utilized in formulations that require precise control over vascular tone and neurotransmitter activity, offering prescribers a versatile tool in patient care. Its efficacy and safety profile make it a preferred choice in personalized medicine, where tailored treatment regimens are essential for optimal patient outcomes.

Ergocristine Mesylate's pharmacokinetics and pharmacodynamics are well-studied, ensuring that healthcare providers can rely on its predictable effects and interactions. When considering its use, it is important for prescribers to be aware of potential contraindications and to monitor patients for any adverse reactions. This ensures that the therapeutic benefits of Ergocristine Mesylate are maximized while minimizing any risks associated with its use.

Formulas using

Ergocristine Mesylate

Formulas and/or material listed are not to be interpreted as a promise, guarantee or claim of therapeutic efficacy or safety. The information contained herein is not intended to replace or substitute for conventional medical care, or encourage its abandonment. Every patient is unique, and formulas should be adjusted to meet their individual needs.

No compounded medications are reviewed by the FDA for safety or efficacy.